A controversial study on the costs of unnecessary mammography, published in the April issue of Health Affairs, contains “serious methodological flaws,” said Richard Wender, chief cancer control officer at the American Cancer Society.
An analysis by researchers from the International Agency for Research on Cancer casts doubt on validity of an endpoint used in key studies of multi-cancer detection tests.
